-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
April 10, 2020 - “Depression Chronicity: In a sample with
comorbid depression and substance use
disorder, those with … Comparison of
moclobemide and placebo in young
adolescents with major depressive
disorder. … Efficacy of sertraline in the treatment of children and adolescents with major
depressive disorder: … Comparison of moclobemide and placebo in young adolescents with major depressive
disorder. … Pharmacological and non-pharmacological treatments for major depressive
disorder: review of systematic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
November 04, 2020 - Comparative Effectiveness Review 235_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder … Research Review Title: Pharmacologic and Nonpharmacologic Treatments for
Posttraumatic Stress Disorder … Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An
Update of the PTSD-Repository … Additionally,
Page v – review methods- substance use (not
used) disorder and Appendix G, first paragraph … We appreciate the inclusion of comorbid
PTSD/substance use disorder.
Noted.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - • Research to develop and validate instruments
for accurately predicting risk of opioid use
disorder … studies on opioids to evaluate
longer-term outcomes, including associated
harms (e.g., opioid use disorder … including pain, function,
quality of life, sleep, mental health outcomes,
misuse, and opioid use disorder … • Studies that address subpopulations, including,
individuals with a history of substance use
disorder … studies should continue to examine how
patient baseline characteristics (history of
substance abuse disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
July 31, 2024 - Insufficient evidence to make conclusions for
bipolar disorder, obsessive-compulsive disorder,
post-traumatic … stress disorder, anxiety
disorders, obsessive -compulsive disorders and
non-pharmacological versus … studies as testing an IPT
intervention if they referenced
IPT principles and aimed to treat
the disorder … Maternal History of Adverse Experiences and
Posttraumatic Stress Disorder Symptoms
Impact Toddlers'
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
November 15, 2012 - The patient and the parent will be asked about their
experiences with the disorder prior to ERT and … outcomes in patients with one of the 6 LSDs
under consideration who received specific ERT for that disorder … Product (approval
date)
MPS I (Hurler
disease),
1/100,000 live
births
MPS I is a variable disorder … 155,000 live
births
(1/34,000 live
births in Israeli
Jewish population)
MPS II is an X-linked disorder … Pharmaceutical Inc
(June 2005)
Fabry’s disease,
1/40,000 live male
births
Fabry’s disease is an X-linked disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - : mean ≥5 on NRS pain scale
Exclusions: Patients with hip/knee/shoulder osteoarthritis; psychiatric disorder … from PCP
Exclusion: member of vulnerable population (including prisoners); co-occurring psychiatric disorder … Exclusion: Received past year treatment for opioid use disorder, cancer, dementia, or end-of-life care … vs. 5%
Other: 52% vs. 3% vs. 2%
Hispanic: 3% vs. 4% vs. 6%
Not reported: 5% vs. 2% vs. 2%
Opioid use disorder … : 9% vs. 9% vs. 7%
Alcohol use disorder: 2% vs. 9% vs. 8%
Concurrent benzodiazepine: 27% vs. 23% vs.
-
effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update
-
effectivehealthcare.ahrq.gov/products/opioids-older-adults/report
-
effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-protocol
-
effectivehealthcare.ahrq.gov/products/opioids-older-adults/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
January 01, 2022 - severity at previous study wave, age, sex, duration of pain, oral morphine equivalent, generalized anxiety disorder … lifetime International Statistical Classification of Diseases and Related Health Problems, substance use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-facilitating-implementation-pilot.pdf
October 01, 2019 - After identifying the target report on attention deficit
hyperactivity disorder (ADHD), we gathered … However, HealthPartners expressed
interest in the topic of attention deficit-hyperactivity disorder … improvement initiative.
8
Abbreviations and Acronyms
ADHD Attention-Deficit/Hyperactivity Disorder … Attention
Deficit Hyperactivity Disorder: Diagnosis and
Treatment in Children and Adolescents. … Attention
Deficit Hyperactivity Disorder: Effectiveness of
Treatment in At-Risk Preschoolers; Long-Term
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/outcome-research-white-paper.pdf
June 01, 2022 - Comorbidities of interest for this study were generalized
anxiety disorder, obsessive-compulsive disorder … , panic disorder, post-traumatic stress disorder,
social anxiety disorder, substance use disorder, alcohol … use disorder, bipolar disorder,
schizophrenia, and insomnia. … Generalized anxiety
disorder was mentioned most frequently, followed by bipolar disorder, anxiety disorder … , and
substance use disorder.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - Systematic Review
Overview
Restless legs syndrome (RLS) or Willis-Ekbom disease is a neurological disorder … Severe restless legs syndrome, however, is a
chronic progressive disorder that may require long-term … Studies that report periodic limb movements disorder (PLMD) or other sleep-
related conditions … Periodic leg movements in sleep and
periodic limb movement disorder: Prevalence, clinical significance … However, PLM are not specific to RLS and
PLMD is a distinct sleep disorder.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-pharm-non-pharm-treatment-update-disposition-comments.pdf
August 28, 2024 - of Comments_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder … Comments Report
Title: Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder … Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress
Disorder: 2024 Update of the … ’s Draft Systematic Review
Pharmacologic and Nonpharmacologic Treatments for
Posttraumatic Stress Disorder
-
effectivehealthcare.ahrq.gov/products/autism/research
-
effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research
-
effectivehealthcare.ahrq.gov/products/anxiety-children/research-2017
-
effectivehealthcare.ahrq.gov/products/pain-management-substance-abuse/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_disposition-comments.pdf
August 27, 2012 - impairments, obesity, depression, anxiety, acute
and episodic aggression, attention deficit
hyperactivity disorder